What are the risk factors for tendon rupture associated with ciprofloxacin use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Risk Factors for Tendon Rupture with Ciprofloxacin

The most critical risk factors for ciprofloxacin-associated tendon rupture are age over 60 years and concurrent corticosteroid use, which together increase the risk of Achilles tendon rupture by more than 40-fold. 1

Established High-Risk Factors

The FDA drug label and guideline evidence clearly identify a hierarchy of risk factors 1, 2:

Primary Risk Factors (Strongest Evidence)

  • Age >60 years: Risk increases 4-fold in this population, with 1 Achilles tendon rupture expected per 1,638 fluoroquinolone-treated patients over 60 2
  • Concurrent corticosteroid use: When combined with fluoroquinolones, the odds ratio for Achilles tendon rupture reaches 43.2 (95% CI: 5.5-341.1) 2
  • Combined age >60 + corticosteroids: Expect 1 Achilles tendon rupture per 979 patients—the highest risk scenario 2

Organ Transplant Recipients

  • Kidney, heart, or lung transplants: Explicitly highlighted in the FDA boxed warning as high-risk 1
  • These patients often have multiple compounding factors (corticosteroid use, renal dysfunction)

Secondary Risk Factors

The following conditions are commonly reported in fluoroquinolone-associated tendon disorders, though their independent risk has not been formally quantified 2:

Renal Disease

  • End-stage kidney disease
  • Hemodialysis
  • Renal failure 3, 4

Rheumatologic Conditions

  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Polymyalgia rheumatica

Metabolic Disorders

  • Diabetes mellitus 5, 4
  • Hyperparathyroidism
  • Hypothyroidism
  • Lipid disorders 4

Other Medical Conditions

  • Inflammatory bowel disease (Crohn disease, ulcerative colitis)
  • Obesity 4
  • Cardiac disease 4

Activity-Related Factors

  • Participation in sports: 50% of tendon disorders in athletes occurred during sports participation 2
  • Strenuous physical activity 1
  • Previous tendon disorders or trauma 2, 1

Nutritional Factors

  • Magnesium deficiency: Experimental evidence suggests protective effects of magnesium supplementation against fluoroquinolone-induced tendon damage 2

Timing and Clinical Context

Critical timing consideration: The highest risk period is within 15 days of starting ciprofloxacin (current use), with adjusted relative risk of 1.9 for Achilles tendon disorders 2. However, tendon rupture can occur up to 6 months after discontinuation 2, 1.

Important Caveats

  • Gender is NOT a reliable risk factor despite some reports suggesting female predominance 2
  • The absolute risk remains relatively low even in high-risk groups: 12 cases per 100,000 persons within 90 days of treatment 2
  • Achilles tendon is most commonly affected (90% of cases), but ruptures can occur in rotator cuff, biceps, patellar, and other tendons 2, 1

Clinical Decision-Making Algorithm

When prescribing ciprofloxacin, stratify patients:

Highest Risk (avoid if alternatives exist):

  • Age >60 + concurrent corticosteroids
  • Organ transplant recipients on immunosuppression
  • Active athletes with any additional risk factor

High Risk (use with extreme caution):

  • Age >60 alone
  • Corticosteroid use alone
  • End-stage renal disease/dialysis
  • Multiple secondary risk factors

Moderate Risk (counsel and monitor):

  • Age 18-60 with diabetes, rheumatologic disease, or previous tendon injury
  • Athletes without other risk factors

Action required: Discontinue immediately at first sign of tendon pain, swelling, or inflammation and advise complete rest 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.